Curaleaf Holdings (CURLF) Non-cash Items (2021 - 2022)

Curaleaf Holdings (CURLF) recorded quarterly Non-cash Items of $69.1 million in Q4 2022, down 16.95% quarter-over-quarter from $83.2 million in Q4 2021, and down 16.95% on a YoY basis from $83.2 million in Q4 2021.

Curaleaf Holdings (CURLF) Non-cash Items (2021 - 2022) Analysis & Trends

Curaleaf Holdings' Non-cash Items history runs 2 years deep, the most recent figure standing at $69.1 million for Q4 2022.

  • In Q4 2022, Non-cash Items fell 16.95% year-over-year to $69.1 million; the TTM figure through Dec 2022 stood at $69.1 million (down 16.95% YoY), while the FY2021 annual figure was $83.2 million, changed N/A from the prior year.
  • Non-cash Items was $69.1 million for Q4 2022 at Curaleaf Holdings, down from $83.2 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $83.2 million in Q4 2021 to a low of $69.1 million in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn
10 Curaleaf Holdings - - 157.29 Mn

Historic Data

Download Data
DateValue
Dec 31, 2022 69.10 Mn
Dec 31, 2022 69.10 Mn
Dec 31, 2021 83.20 Mn
Dec 31, 2021 83.20 Mn